nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—saliva—acquired immunodeficiency syndrome	0.0256	0.105	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—acquired immunodeficiency syndrome	0.0126	0.0516	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—acquired immunodeficiency syndrome	0.0113	0.0462	CbGeAlD
Aminosalicylic Acid—MPO—blood plasma—acquired immunodeficiency syndrome	0.0112	0.0458	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—acquired immunodeficiency syndrome	0.00911	0.0374	CbGeAlD
Aminosalicylic Acid—CHUK—digestive system—acquired immunodeficiency syndrome	0.009	0.037	CbGeAlD
Aminosalicylic Acid—CHUK—blood—acquired immunodeficiency syndrome	0.00858	0.0352	CbGeAlD
Aminosalicylic Acid—CHUK—lung—acquired immunodeficiency syndrome	0.00752	0.0309	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00596	0.0245	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—acquired immunodeficiency syndrome	0.0057	0.0234	CbGeAlD
Aminosalicylic Acid—MPO—skin of body—acquired immunodeficiency syndrome	0.00536	0.022	CbGeAlD
Aminosalicylic Acid—CHUK—brain—acquired immunodeficiency syndrome	0.00532	0.0218	CbGeAlD
Aminosalicylic Acid—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00529	0.0217	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—acquired immunodeficiency syndrome	0.00514	0.0211	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.00513	0.0211	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—acquired immunodeficiency syndrome	0.00507	0.0208	CbGeAlD
Aminosalicylic Acid—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00506	0.0208	CbGeAlD
Aminosalicylic Acid—ALOX5—blood—acquired immunodeficiency syndrome	0.00483	0.0198	CbGeAlD
Aminosalicylic Acid—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.00467	0.0192	CbGeAlD
Aminosalicylic Acid—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00434	0.0178	CbGeAlD
Aminosalicylic Acid—MPO—digestive system—acquired immunodeficiency syndrome	0.00429	0.0176	CbGeAlD
Aminosalicylic Acid—ALOX5—lung—acquired immunodeficiency syndrome	0.00424	0.0174	CbGeAlD
Aminosalicylic Acid—MPO—blood—acquired immunodeficiency syndrome	0.00409	0.0168	CbGeAlD
Aminosalicylic Acid—MPO—bone marrow—acquired immunodeficiency syndrome	0.00396	0.0162	CbGeAlD
Aminosalicylic Acid—MPO—spinal cord—acquired immunodeficiency syndrome	0.00394	0.0162	CbGeAlD
Aminosalicylic Acid—ALOX5—nervous system—acquired immunodeficiency syndrome	0.00392	0.0161	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.00378	0.0155	CbGeAlD
Aminosalicylic Acid—MPO—lung—acquired immunodeficiency syndrome	0.00358	0.0147	CbGeAlD
Aminosalicylic Acid—MPO—nervous system—acquired immunodeficiency syndrome	0.00332	0.0136	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—acquired immunodeficiency syndrome	0.0032	0.0131	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—acquired immunodeficiency syndrome	0.003	0.0123	CbGeAlD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00293	0.0258	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—lymph node—acquired immunodeficiency syndrome	0.0029	0.0119	CbGeAlD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—CCL5—acquired immunodeficiency syndrome	0.00278	0.0245	CbGpPWpGaD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00268	0.0236	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00254	0.0104	CbGeAlD
Aminosalicylic Acid—MPO—brain—acquired immunodeficiency syndrome	0.00254	0.0104	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—acquired immunodeficiency syndrome	0.00245	0.0101	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00243	0.00999	CbGeAlD
Aminosalicylic Acid—MPO—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00211	0.0186	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00204	0.00836	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00203	0.0179	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00197	0.00809	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00196	0.0173	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00195	0.00799	CbGeAlD
Aminosalicylic Acid—PTGS1—blood—acquired immunodeficiency syndrome	0.00194	0.00796	CbGeAlD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.00191	0.0168	CbGpPWpGaD
Aminosalicylic Acid—Diflunisal—ALB—acquired immunodeficiency syndrome	0.00187	0.643	CrCbGaD
Aminosalicylic Acid—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00187	0.00767	CbGeAlD
Aminosalicylic Acid—PTGS2—blood—acquired immunodeficiency syndrome	0.00185	0.00761	CbGeAlD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00182	0.016	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.0018	0.0159	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—vagina—acquired immunodeficiency syndrome	0.0018	0.00738	CbGeAlD
Aminosalicylic Acid—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00179	0.00736	CbGeAlD
Aminosalicylic Acid—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.00179	0.00733	CbGeAlD
Aminosalicylic Acid—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00178	0.00278	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00178	0.00278	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00178	0.00277	CcSEcCtD
Aminosalicylic Acid—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.00177	0.00277	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.00276	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00176	0.00275	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00176	0.00275	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00175	0.00274	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00175	0.00273	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00174	0.00271	CcSEcCtD
Aminosalicylic Acid—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00173	0.00271	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.0027	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00173	0.0027	CcSEcCtD
Aminosalicylic Acid—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00173	0.0027	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.0027	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00172	0.0151	CbGpPWpGaD
Aminosalicylic Acid—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00269	CcSEcCtD
Aminosalicylic Acid—PTGS2—vagina—acquired immunodeficiency syndrome	0.00172	0.00705	CbGeAlD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.00172	0.0151	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00171	0.00267	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.0017	0.00266	CcSEcCtD
Aminosalicylic Acid—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.0017	0.00266	CcSEcCtD
Aminosalicylic Acid—PTGS1—lung—acquired immunodeficiency syndrome	0.0017	0.00698	CbGeAlD
Aminosalicylic Acid—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00265	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00264	CcSEcCtD
Aminosalicylic Acid—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00261	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.0026	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00259	CcSEcCtD
Aminosalicylic Acid—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.00166	0.00259	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00165	0.00258	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00165	0.00258	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.00257	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00256	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00255	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00163	0.00255	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.00163	0.00254	CcSEcCtD
Aminosalicylic Acid—PTGS2—lung—acquired immunodeficiency syndrome	0.00163	0.00667	CbGeAlD
Aminosalicylic Acid—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00254	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00162	0.00253	CcSEcCtD
Aminosalicylic Acid—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.0025	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00248	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00248	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00158	0.00247	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00158	0.00246	CcSEcCtD
Aminosalicylic Acid—PTGS1—nervous system—acquired immunodeficiency syndrome	0.00157	0.00646	CbGeAlD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00157	0.0138	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00157	0.00245	CcSEcCtD
Aminosalicylic Acid—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.00245	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00157	0.00245	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00157	0.00245	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00155	0.00243	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00155	0.00242	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00241	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00154	0.00241	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00154	0.00241	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—TAT—acquired immunodeficiency syndrome	0.00154	0.0135	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00154	0.0024	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00153	0.00239	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00152	0.00237	CcSEcCtD
Aminosalicylic Acid—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00152	0.00622	CbGeAlD
Aminosalicylic Acid—PTGS2—nervous system—acquired immunodeficiency syndrome	0.0015	0.00618	CbGeAlD
Aminosalicylic Acid—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.0015	0.00235	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00235	CcSEcCtD
Aminosalicylic Acid—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00235	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.00149	0.0131	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00149	0.00233	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.00232	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00232	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00232	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00148	0.00232	CcSEcCtD
Aminosalicylic Acid—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00231	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.0023	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00228	CcSEcCtD
Aminosalicylic Acid—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00146	0.00228	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.00227	CcSEcCtD
Aminosalicylic Acid—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.00145	0.00595	CbGeAlD
Aminosalicylic Acid—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00226	CcSEcCtD
Aminosalicylic Acid—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00144	0.00226	CcSEcCtD
Aminosalicylic Acid—CHUK—BCR signaling pathway—CD79A—acquired immunodeficiency syndrome	0.00144	0.0127	CbGpPWpGaD
Aminosalicylic Acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00226	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00226	CcSEcCtD
Aminosalicylic Acid—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00144	0.00225	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00144	0.00225	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00144	0.00225	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00225	CcSEcCtD
Aminosalicylic Acid—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00224	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00224	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00224	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00224	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00224	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00143	0.00223	CcSEcCtD
Aminosalicylic Acid—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Aminosalicylic Acid—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00142	0.00222	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00221	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00141	0.00221	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00141	0.00221	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.0014	0.0124	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.0014	0.0123	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.0014	0.00218	CcSEcCtD
Aminosalicylic Acid—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00217	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00138	0.00216	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00215	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00214	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.00136	0.012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.00136	0.012	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00136	0.00213	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00136	0.00213	CcSEcCtD
Aminosalicylic Acid—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.00212	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00212	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00212	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00211	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.00135	0.0119	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.0021	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.0021	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00134	0.00209	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00134	0.00209	CcSEcCtD
Aminosalicylic Acid—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00209	CcSEcCtD
Aminosalicylic Acid—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00133	0.00208	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.00133	0.0117	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Aminosalicylic Acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.00131	0.0116	CbGpPWpGaD
Aminosalicylic Acid—Headache—Didanosine—acquired immunodeficiency syndrome	0.00131	0.00204	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00131	0.0115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.00131	0.0115	CbGpPWpGaD
Aminosalicylic Acid—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00203	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00202	CcSEcCtD
Aminosalicylic Acid—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—acquired immunodeficiency syndrome	0.00129	0.0114	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00201	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00201	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00128	0.00201	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00128	0.0112	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00199	CcSEcCtD
Aminosalicylic Acid—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00199	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00198	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00198	CcSEcCtD
Aminosalicylic Acid—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Aminosalicylic Acid—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00195	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00195	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00194	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00124	0.00194	CcSEcCtD
Aminosalicylic Acid—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00124	0.00194	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00193	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00188	CcSEcCtD
Aminosalicylic Acid—PTGS1—brain—acquired immunodeficiency syndrome	0.0012	0.00494	CbGeAlD
Aminosalicylic Acid—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0012	0.00188	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00188	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00188	CcSEcCtD
Aminosalicylic Acid—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.0012	0.00187	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00187	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00187	CcSEcCtD
Aminosalicylic Acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00119	0.00187	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00186	CcSEcCtD
Aminosalicylic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00185	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00185	CcSEcCtD
Aminosalicylic Acid—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00118	0.00185	CcSEcCtD
Aminosalicylic Acid—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00184	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00118	0.0103	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00183	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00182	CcSEcCtD
Aminosalicylic Acid—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00182	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—acquired immunodeficiency syndrome	0.00116	0.00477	CbGeAlD
Aminosalicylic Acid—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Aminosalicylic Acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Aminosalicylic Acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Aminosalicylic Acid—PTGS2—brain—acquired immunodeficiency syndrome	0.00115	0.00472	CbGeAlD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00115	0.0101	CbGpPWpGaD
Aminosalicylic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00115	0.00179	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00115	0.00179	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00179	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00179	CcSEcCtD
Aminosalicylic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00179	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00179	CcSEcCtD
Aminosalicylic Acid—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Aminosalicylic Acid—Headache—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Aminosalicylic Acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00114	0.00999	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00177	CcSEcCtD
Aminosalicylic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.00113	0.00176	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00113	0.00176	CcSEcCtD
Aminosalicylic Acid—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00176	CcSEcCtD
Aminosalicylic Acid—Headache—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00175	CcSEcCtD
Aminosalicylic Acid—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00112	0.00174	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00111	0.00979	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymph node—acquired immunodeficiency syndrome	0.00111	0.00456	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Aminosalicylic Acid—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Aminosalicylic Acid—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Aminosalicylic Acid—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00108	0.00168	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.00107	0.00946	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00166	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.00106	0.00936	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00106	0.00166	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.00106	0.00933	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00165	CcSEcCtD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.00105	0.00928	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—TNF—acquired immunodeficiency syndrome	0.00105	0.00928	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00165	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00105	0.00924	CbGpPWpGaD
Aminosalicylic Acid—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Aminosalicylic Acid—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—acquired immunodeficiency syndrome	0.00104	0.357	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.0016	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00159	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.00102	0.00897	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00159	CcSEcCtD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.00102	0.00896	CbGpPWpGaD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00102	0.00895	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00102	0.00893	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.001	0.00157	CcSEcCtD
Aminosalicylic Acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.001	0.00157	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00157	CcSEcCtD
Aminosalicylic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000994	0.00155	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000993	0.00155	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—CD4—acquired immunodeficiency syndrome	0.000991	0.00872	CbGpPWpGaD
Aminosalicylic Acid—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000987	0.00154	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000978	0.00153	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000976	0.00153	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000973	0.00152	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000971	0.00152	CcSEcCtD
Aminosalicylic Acid—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000969	0.00151	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000969	0.00151	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000969	0.00151	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000964	0.00151	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000958	0.00843	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000948	0.00148	CcSEcCtD
Aminosalicylic Acid—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000937	0.00146	CcSEcCtD
Aminosalicylic Acid—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000936	0.00146	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000932	0.00146	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000932	0.00146	CcSEcCtD
Aminosalicylic Acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000932	0.00146	CcSEcCtD
Aminosalicylic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.000924	0.00144	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000923	0.00144	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.00144	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.00092	0.00809	CbGpPWpGaD
Aminosalicylic Acid—Headache—Indinavir—acquired immunodeficiency syndrome	0.000918	0.00144	CcSEcCtD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000917	0.00807	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000916	0.00143	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000907	0.00142	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000903	0.00141	CcSEcCtD
Aminosalicylic Acid—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000894	0.0014	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000889	0.00139	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000889	0.00139	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000882	0.00776	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000881	0.00138	CcSEcCtD
Aminosalicylic Acid—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000876	0.00137	CcSEcCtD
Aminosalicylic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000873	0.00136	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000872	0.00136	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000872	0.00767	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000871	0.00136	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000869	0.00136	CcSEcCtD
Aminosalicylic Acid—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000868	0.00136	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000858	0.00755	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000845	0.00743	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000842	0.00132	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000841	0.0074	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000838	0.00131	CcSEcCtD
Aminosalicylic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000835	0.00131	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000835	0.0013	CcSEcCtD
Aminosalicylic Acid—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00083	0.0013	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.00083	0.0073	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000829	0.0013	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000827	0.00728	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000823	0.00129	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00082	0.00722	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00081	0.00127	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000807	0.00126	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.000807	0.0071	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000802	0.00705	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000795	0.00699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—acquired immunodeficiency syndrome	0.00079	0.00695	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000787	0.00123	CcSEcCtD
Aminosalicylic Acid—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00078	0.00122	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000779	0.00122	CcSEcCtD
Aminosalicylic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000773	0.00121	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000772	0.00121	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00077	0.0012	CcSEcCtD
Aminosalicylic Acid—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000768	0.0012	CcSEcCtD
Aminosalicylic Acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00075	0.00117	CcSEcCtD
Aminosalicylic Acid—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000744	0.00116	CcSEcCtD
Aminosalicylic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000744	0.00116	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.00116	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling—CD4—acquired immunodeficiency syndrome	0.00074	0.00652	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.00074	0.00651	CbGpPWpGaD
Aminosalicylic Acid—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000739	0.00115	CcSEcCtD
Aminosalicylic Acid—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000728	0.00114	CcSEcCtD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000728	0.0064	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000715	0.00112	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000712	0.00627	CbGpPWpGaD
Aminosalicylic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000709	0.00111	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000709	0.00111	CcSEcCtD
Aminosalicylic Acid—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000705	0.0011	CcSEcCtD
Aminosalicylic Acid—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000701	0.00109	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000677	0.00596	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000668	0.00104	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000667	0.00587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000659	0.0058	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000657	0.00578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000651	0.00573	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000623	0.00548	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00062	0.00546	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000615	0.00541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000606	0.00533	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TAT—acquired immunodeficiency syndrome	0.000602	0.0053	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000602	0.0053	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000587	0.00517	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00053	0.00467	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000528	0.00465	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000526	0.00462	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000525	0.00462	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000518	0.00456	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000515	0.00453	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000512	0.00451	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.0005	0.0044	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000499	0.00439	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000474	0.00417	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000461	0.00405	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000458	0.00403	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000455	0.00401	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000432	0.0038	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.00042	0.0037	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000415	0.00366	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000396	0.00348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000376	0.00331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000374	0.00329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000374	0.00329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000371	0.00326	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000361	0.00318	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000359	0.00316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000357	0.00314	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000348	0.00306	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000336	0.00295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000334	0.00294	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000331	0.00291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	0.00033	0.00291	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00033	0.0029	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000328	0.00289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00032	0.00282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000299	0.00263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000296	0.00261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000295	0.0026	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000291	0.00256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000286	0.00251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCNT1—acquired immunodeficiency syndrome	0.000284	0.0025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.000281	0.00247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000281	0.00247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000276	0.00243	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000269	0.00237	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ALB—acquired immunodeficiency syndrome	0.000268	0.00236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000267	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000266	0.00234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	0.000265	0.00233	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000261	0.0023	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000261	0.0023	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000258	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.00025	0.0022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000248	0.00218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000247	0.00217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	0.000238	0.0021	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000236	0.00208	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000232	0.00204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	0.000224	0.00197	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000222	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000221	0.00194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MBL2—acquired immunodeficiency syndrome	0.000219	0.00193	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000217	0.00191	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000213	0.00188	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000207	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000202	0.00178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000202	0.00178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.0002	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.0002	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000199	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000199	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000199	0.00175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000199	0.00175	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000198	0.00174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000196	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000194	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000192	0.00169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000191	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000188	0.00165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00018	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000179	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000178	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000178	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000177	0.00156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000176	0.00155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000172	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CCR2—acquired immunodeficiency syndrome	0.000172	0.00151	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000169	0.00149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000168	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000166	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000166	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000166	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000165	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000163	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000163	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000155	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD79A—acquired immunodeficiency syndrome	0.00015	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CXCR4—acquired immunodeficiency syndrome	0.000149	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000147	0.0013	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000136	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000123	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000123	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—acquired immunodeficiency syndrome	0.000121	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CSF2—acquired immunodeficiency syndrome	0.000121	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000119	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000117	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.000115	0.00101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000115	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000115	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000113	0.000997	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000111	0.000978	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	0.000105	0.000924	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000105	0.00092	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000105	0.00092	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—acquired immunodeficiency syndrome	0.000102	0.0009	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000102	0.0009	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	8.84e-05	0.000778	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.12e-05	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-05	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.83e-05	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—acquired immunodeficiency syndrome	7.2e-05	0.000634	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.16e-05	0.00063	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—acquired immunodeficiency syndrome	6.96e-05	0.000612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.46e-05	0.000569	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—acquired immunodeficiency syndrome	6.42e-05	0.000565	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—acquired immunodeficiency syndrome	6.4e-05	0.000563	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	6.06e-05	0.000533	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	4.56e-05	0.000401	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-05	0.000364	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	3.81e-05	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—acquired immunodeficiency syndrome	3.76e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	3.62e-05	0.000318	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—acquired immunodeficiency syndrome	3.47e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.06e-05	0.000181	CbGpPWpGaD
